Drug intelligence / Profile preview

chlorobutanol + saline

Development stage
Unknown
Modality
Small Molecules
Administration
Inhalation
01

Overview

A combination of chlorobutanol, a preservative with antimicrobial properties, and saline solution. This combination is primarily used in nebulizer solutions as a bacteriostatic preservative that does not cause bronchoconstriction in asthmatic patients. Chlorobutanol disrupts microbial cell membranes and inhibits voltage-gated sodium channels, which may contribute to its mild analgesic effects. ## Properties and Uses Chlorobutanol is a chemical preservative with antibacterial and antifungal properties that is typically used at a concentration of 0.5% to provide long-term stability to multi-ingredient formulations[1][3]. When combined with saline, it creates a bacteriostatic solution that can be safely used in nebulizer treatments without causing bronchoconstriction[4]. ## Mechanism of Action Chlorobutanol works by disrupting the lipid structure of microbial cell membranes, increasing cell permeability and leading to cell lysis[1]. It also inhibits voltage-gated sodium channels at concentrations lower than those used as preservatives, which may contribute to its mild analgesic effects[8]. ## Clinical Applications The chlorobutanol + saline combination has been specifically studied for use in nebulizer solutions, where it demonstrated effective bacteriostatic properties against a range of bacteria and yeasts for up to 28 days[4]. Importantly, when tested in asthmatic subjects, this combination did not cause bronchoconstriction or changes in FEV1 (forced expiratory volume in 1 second), making it a safe preservative option for respiratory medications[4]. ## Safety Profile Studies have shown that chlorobutanol + saline can be safely used in nebulizer solutions without triggering bronchospasm in asthmatic patients[4]. This makes it a valuable alternative to other preservatives that might cause airway irritation or bronchoconstriction.

02

Targets

KCNH2 (Voltage-gated potassium channel subfamily H member 2)SCN2A (Voltage-gated sodium channel protein type 2 subunit alpha)

Beyond the preview

Go deeper on chlorobutanol + saline.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on chlorobutanol + saline.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call